Compare SAP SE (SAP) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SAP SE vs 10X Genomics Inc — how do they compare? SAP SE trades at $154.5 (market cap $183.83B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: SAP SE is far larger — about 33.5× 10X Genomics Inc's market cap, and SAP SE pays a 1.85% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| SAP | TXG | |
|---|---|---|
Market Cap | $183.83B | $5.48B |
Sector | Technology | Health |
52-Week High | $307.27 | $45.80 |
52-Week Low | $148.06 | $11.34 |
Enterprise Value | $181.35B | $5.02B |
Dividend Yield | 1.85% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
